OGG1S326C variant frequent in human populations facilitates inflammatory responses due to its extended interaction with DNA substrate

J Jinling Han (Division of Human Health, Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University) M Meichen Zhang (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) J Jiakun Ge (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) Z Zhihua Ji (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) J Jianyi Zhao (Department of Respiratory Medicine, China-Japan Union Hospital of Jilin University) Y Yinchao Hu (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) C Chunshuang Li (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) Y Yaoyao Xue (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) X Xining Li (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) H Haiwang Zhao (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) Z Zixu Cui (Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University) M Miaomiao Tian (Division of Human Health, Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University) X Xu Zheng (Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University) D Dapeng Wang J Jing Wang (Hunan Cancer Hospital Changsha China) M Min Wei (Department of Chemistry and Key Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province) Z Zsolt Radak (Research Center for Molecular Exercise Science, Institute of Sport Science, University of Physical Education) Y Yusaku Nakabeppu (Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University) I Istvan Boldogh (Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston) X Xueqing Ba

Abstract

8-oxoguanine (8-oxoGua) is one of the most frequent forms of oxidative DNA base lesions, repaired by 8-oxoguanine DNA glycosylase 1 (OGG1) via base excision repair (BER) pathway to maintain genome fidelity. The human allelic variant hOGG1 S326C , prevalent in Caucasians and Asians, has been regarded as a susceptibility factor for various diseases, yet its pathogenic mechanism remains elusive. In this study, we demonstrate that Ogg1 S326C/S326C mice exhibit increased and sustained airway inflammation compared with wild-type (WT) Ogg1 S326/S326 mice. Mechanistically, in response to inflammatory stimulation, OGG1S326C undergoes reactive oxygen species-induced dimerization, which impairs its base excision function, but prolongs its association with promoter-embedded substrate(s), leading to an increase in NF-κB’ DNA occupancy, subsequently the excessive expression of proinflammatory cytokines and chemokines, and the exacerbated lung inflammation. In contrast, Serine at position 326 in WT -OGG1 is constitutively phosphorylated by CDK4. To fulfill the requirement for its function in transcriptional regulation, the phosphorylated OGG1 needs to undergo dephosphorylation to rescue DNA binding ability. In this scenario, OGG1S326C lacks this phosphorylation site, disrupting this regulatory cycle. Notably, administration of a small molecule inhibitor of OGG1 prevents OGG1S326C from binding to DNA and significantly decreases gene expression and inflammatory responses. Our findings elucidate a molecular basis for the increased disease susceptibility of individuals carrying the hOGG1 S326C variant and propose the therapeutic potential of OGG1 inhibitors in mitigating inflammation-driven pathologies.

Article Details

Volume / Issue Vol. 122, Issue 19
Published May 13, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (20)

J

Jinling Han

Division of Human Health, Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University

M

Meichen Zhang

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

J

Jiakun Ge

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

Z

Zhihua Ji

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

J

Jianyi Zhao

Department of Respiratory Medicine, China-Japan Union Hospital of Jilin University

Y

Yinchao Hu

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

C

Chunshuang Li

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

Y

Yaoyao Xue

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

X

Xining Li

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

H

Haiwang Zhao

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

Z

Zixu Cui

Division of Human Health, Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University

M

Miaomiao Tian

Division of Human Health, Key Laboratory of Molecular Epigenetics of the Ministry of Education, Northeast Normal University

X

Xu Zheng

Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Northwest A&F University

D

Dapeng Wang

J

Jing Wang

Hunan Cancer Hospital Changsha China

M

Min Wei

Department of Chemistry and Key Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province

Z

Zsolt Radak

Research Center for Molecular Exercise Science, Institute of Sport Science, University of Physical Education

Y

Yusaku Nakabeppu

Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University

I

Istvan Boldogh

Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston

X

Xueqing Ba